Jinhai Medical Technology 관리
관리 기준 확인 3/4
We currently do not have sufficient information about the CEO.
주요 정보
Zhenfei Wang
최고 경영자
S$111.0k
총 보상
CEO 급여 비율 | 97.3% |
CEO 임기 | 5.3yrs |
CEO 소유권 | n/a |
경영진 평균 재임 기간 | 1.3yrs |
이사회 평균 재임 기간 | 5.3yrs |
최근 관리 업데이트
Recent updates
Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price
Oct 06The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon
Jun 19Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%
May 13Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%
Mar 17What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You
Jan 31Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital
Jun 06Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital
Mar 07CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -S$10m |
Mar 31 2024 | n/a | n/a | -S$7m |
Dec 31 2023 | S$111k | S$108k | -S$3m |
Sep 30 2023 | n/a | n/a | -S$2m |
Jun 30 2023 | n/a | n/a | S$6k |
Mar 31 2023 | n/a | n/a | S$237k |
Dec 31 2022 | S$240k | S$237k | S$468k |
Sep 30 2022 | n/a | n/a | S$443k |
Jun 30 2022 | n/a | n/a | S$419k |
Mar 31 2022 | n/a | n/a | S$86k |
Dec 31 2021 | S$356k | S$353k | -S$246k |
Sep 30 2021 | n/a | n/a | S$320k |
Jun 30 2021 | n/a | n/a | S$852k |
Mar 31 2021 | n/a | n/a | S$1m |
Dec 31 2020 | S$365k | S$362k | S$1m |
Sep 30 2020 | n/a | n/a | S$516k |
Jun 30 2020 | n/a | n/a | -S$231k |
Mar 31 2020 | n/a | n/a | -S$459k |
Dec 31 2019 | S$362k | S$161k | -S$686k |
보상 대 시장: Zhenfei's total compensation ($USD84.37K) is below average for companies of similar size in the Hong Kong market ($USD495.13K).
보상과 수익: Zhenfei's compensation has been consistent with company performance over the past year.
CEO
Zhenfei Wang (43 yo)
5.3yrs
테뉴어
S$111,000
보상
Mr. Zhenfei Wang has been Chief Executive Officer and Executive Director of Jinhai Medical Technology Limited (formerly known as Jinhai International Group Holdings Limited) (formerly known as Kakiko Group...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Executive Chairman of the Board | 5.3yrs | S$337.00k | 48.94% HK$ 3.9b | |
CEO & Executive Director | 5.3yrs | S$111.00k | 데이터 없음 | |
Executive Director | 1.3yrs | S$86.00k | 데이터 없음 | |
Chief Financial Officer | 5yrs | 데이터 없음 | 데이터 없음 | |
Chief Technical Officer | less than a year | 데이터 없음 | 데이터 없음 | |
Chief Marketing Officer | less than a year | 데이터 없음 | 데이터 없음 | |
Company Secretary | less than a year | 데이터 없음 | 데이터 없음 |
1.3yrs
평균 재임 기간
50.5yo
평균 연령
경험이 풍부한 관리: 2225's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Executive Chairman of the Board | 5.3yrs | S$337.00k | 48.94% HK$ 3.9b | |
CEO & Executive Director | 5.3yrs | S$111.00k | 데이터 없음 | |
Executive Director | 5.3yrs | S$86.00k | 데이터 없음 | |
Non-Executive Director | 1.3yrs | S$13.00k | 데이터 없음 | |
Non-Executive Director | 5.3yrs | S$33.00k | 데이터 없음 | |
Independent Non-Executive Director | 5.3yrs | S$21.00k | 데이터 없음 | |
Independent Non-Executive Director | 5.3yrs | S$21.00k | 데이터 없음 | |
Independent Non-Executive Director | 2.8yrs | S$21.00k | 데이터 없음 |
5.3yrs
평균 재임 기간
58.5yo
평균 연령
경험이 풍부한 이사회: 2225's board of directors are considered experienced (5.3 years average tenure).